Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
3
30%
Ph phase_3
5
50%
Ph not_applicable
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

8

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
5(55.6%)
Phase 4Post-market surveillance
3(33.3%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(7)
Completed(3)

Detailed Status

Not yet recruiting5
Completed3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 35 (55.6%)
Phase 43 (33.3%)
N/A1 (11.1%)

Trials by Status

completed330%
recruiting220%
not_yet_recruiting550%

Recent Activity

2 active trials
Showing 5 of 10
not_yet_recruitingphase_4

Butylphthalide for Brain Edema After Endovascular Treatment

NCT07528456
not_yet_recruitingphase_3

Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)

NCT07252544
not_yet_recruitingphase_3

Butylphthalide for Long-term Efficacy in Minor Stroke Study

NCT07230587
recruitingphase_4

Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy

NCT07193277
not_yet_recruitingphase_3

A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI

NCT06704685
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07528456Phase 4

Butylphthalide for Brain Edema After Endovascular Treatment

Not Yet Recruiting
NCT07252544Phase 3

Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)

Not Yet Recruiting
NCT07230587Phase 3

Butylphthalide for Long-term Efficacy in Minor Stroke Study

Not Yet Recruiting
NCT07193277Phase 4

Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy

Recruiting
NCT06704685Phase 3

A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI

Not Yet Recruiting
NCT05086874

Using Real-world Evidence to Analyze the Clinical Effects and Adverse Events of Butylphthalide in Stroke Patients

Completed
NCT05068349Phase 4

For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.

Recruiting
NCT06331494Not Applicable

Efficacy of Butylphthalide on Symptomatic Atherosclerotic Stenosis in Middle Cerebral Artery

Not Yet Recruiting
NCT03539445Phase 3

Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular Treatment

Completed
NCT01405248Phase 3

Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10